CorVel (CRVL) Competitors

$56.99 -1.53 (-2.61%)

Closing price 04:00 PM Eastern

Extended Trading

$57.02 +0.02 (+0.04%)

As of 06:25 PM Eastern

CRVL vs. DVA, CHE, MD, AMN, and CCRN

Should you be buying CorVel stock or one of its competitors? The main competitors of CorVel include DaVita (DVA), Chemed (CHE), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), and Cross Country Healthcare (CCRN). These companies are all part of the "health care services" industry.

How does CorVel compare to DaVita?

CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both health care services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

CorVel has a net margin of 11.23% compared to DaVita's net margin of 5.65%. CorVel's return on equity of 30.15% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.23%	30.15%	17.62%
DaVita	5.65%	-270.37%	4.87%

In the previous week, DaVita had 33 more articles in the media than CorVel. MarketBeat recorded 36 mentions for DaVita and 3 mentions for CorVel. DaVita's average media sentiment score of 0.87 beat CorVel's score of 0.84 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	14 Very Positive mention(s)	3 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market. Comparatively, DaVita has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

51.4% of CorVel shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 44.6% of CorVel shares are owned by company insiders. Comparatively, 1.5% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$895.59M	3.25	$95.17M	$2.04	27.94
DaVita	$13.64B	0.94	$746.80M	$10.78	18.45

DaVita has a consensus target price of $199.17, suggesting a potential upside of 0.15%. Given DaVita's stronger consensus rating and higher probable upside, analysts plainly believe DaVita is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
DaVita	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.38

Summary

DaVita beats CorVel on 10 of the 17 factors compared between the two stocks.

How does CorVel compare to Chemed?

Chemed (NYSE:CHE) and CorVel (NASDAQ:CRVL) are both mid-cap health care services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Chemed currently has a consensus target price of $501.50, suggesting a potential upside of 19.01%. Given Chemed's stronger consensus rating and higher probable upside, research analysts plainly believe Chemed is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Chemed has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market. Comparatively, CorVel has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market.

In the previous week, Chemed had 4 more articles in the media than CorVel. MarketBeat recorded 7 mentions for Chemed and 3 mentions for CorVel. Chemed's average media sentiment score of 1.04 beat CorVel's score of 0.84 indicating that Chemed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has a net margin of 11.23% compared to Chemed's net margin of 10.23%. CorVel's return on equity of 30.15% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.23%	27.18%	17.38%
CorVel	11.23%	30.15%	17.62%

Chemed has higher revenue and earnings than CorVel. Chemed is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.21	$265.24M	$18.35	22.97
CorVel	$895.59M	3.25	$95.17M	$2.04	27.94

95.9% of Chemed shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 3.3% of Chemed shares are owned by company insiders. Comparatively, 44.6% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Chemed beats CorVel on 9 of the 16 factors compared between the two stocks.

How does CorVel compare to Pediatrix Medical Group?

Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by insiders. Comparatively, 44.6% of CorVel shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Pediatrix Medical Group had 11 more articles in the media than CorVel. MarketBeat recorded 14 mentions for Pediatrix Medical Group and 3 mentions for CorVel. CorVel's average media sentiment score of 0.84 beat Pediatrix Medical Group's score of 0.56 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	3 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has a net margin of 11.23% compared to Pediatrix Medical Group's net margin of 9.02%. CorVel's return on equity of 30.15% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	9.02%	19.94%	8.02%
CorVel	11.23%	30.15%	17.62%

Pediatrix Medical Group has higher revenue and earnings than CorVel. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	1.00	$165.39M	$2.06	11.34
CorVel	$895.59M	3.25	$95.17M	$2.04	27.94

Pediatrix Medical Group has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, CorVel has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market.

Pediatrix Medical Group currently has a consensus target price of $22.00, suggesting a potential downside of 5.80%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Pediatrix Medical Group and CorVel tied by winning 8 of the 16 factors compared between the two stocks.

How does CorVel compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 44.6% of CorVel shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, AMN Healthcare Services had 12 more articles in the media than CorVel. MarketBeat recorded 15 mentions for AMN Healthcare Services and 3 mentions for CorVel. CorVel's average media sentiment score of 0.84 beat AMN Healthcare Services' score of 0.65 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	4 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has a net margin of 11.23% compared to AMN Healthcare Services' net margin of -0.95%. CorVel's return on equity of 30.15% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
CorVel	11.23%	30.15%	17.62%

CorVel has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.43	-$95.70M	-$0.87	N/A
CorVel	$895.59M	3.25	$95.17M	$2.04	27.94

AMN Healthcare Services has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, CorVel has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market.

AMN Healthcare Services currently has a consensus target price of $23.50, suggesting a potential downside of 22.78%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, equities analysts plainly believe AMN Healthcare Services is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.44
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

CorVel beats AMN Healthcare Services on 10 of the 17 factors compared between the two stocks.

How does CorVel compare to Cross Country Healthcare?

CorVel (NASDAQ:CRVL) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Cross Country Healthcare has a consensus target price of $12.72, suggesting a potential downside of 3.05%. Given Cross Country Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

In the previous week, Cross Country Healthcare had 20 more articles in the media than CorVel. MarketBeat recorded 23 mentions for Cross Country Healthcare and 3 mentions for CorVel. CorVel's average media sentiment score of 0.84 beat Cross Country Healthcare's score of -0.16 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	0 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral

CorVel has higher earnings, but lower revenue than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$895.59M	3.25	$95.17M	$2.04	27.94
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A

CorVel has a net margin of 11.23% compared to Cross Country Healthcare's net margin of -9.84%. CorVel's return on equity of 30.15% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.23%	30.15%	17.62%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

CorVel has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market.

51.4% of CorVel shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 44.6% of CorVel shares are held by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

CorVel beats Cross Country Healthcare on 10 of the 15 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRVL vs. The Competition

Export

Metric	CorVel	BUSINESS SVCS Industry	Business Sector	NASDAQ Exchange
Market Cap	$2.99B	$5.39B	$6.38B	$12.31B
Dividend Yield	N/A	3.08%	3.07%	5.23%
P/E Ratio	27.94	12.11	31.46	25.70
Price / Sales	3.25	1.43	442.54	78.45
Price / Cash	24.10	11.77	22.61	36.27
Price / Book	9.09	4.80	6.16	6.74
Net Income	$95.17M	$155.84M	$200.03M	$333.09M
7 Day Performance	N/A	N/A	N/A	0.52%
1 Month Performance	8.00%	0.36%	5.75%	8.98%
1 Year Performance	-49.35%	-3.58%	44.20%	42.44%

CorVel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRVL CorVel	1.3166 of 5 stars	$56.99 -2.6%	N/A	-48.0%	$2.99B	$895.59M	27.94	5,075	News Coverage
DVA DaVita	3.3248 of 5 stars	$152.45 -1.1%	$155.80 +2.2%	+38.1%	$10.15B	$13.64B	15.33	78,000	Earnings Report Analyst Forecast Insider Trade
CHE Chemed	4.5418 of 5 stars	$424.28 -0.4%	$501.50 +18.2%	-25.9%	$5.63B	$2.53B	23.13	15,811
MD Pediatrix Medical Group	2.3717 of 5 stars	$20.43 -8.9%	$21.33 +4.4%	+60.5%	$1.68B	$1.91B	10.45	4,315	Earnings Report Analyst Forecast
AMN AMN Healthcare Services	1.3555 of 5 stars	$21.05 +1.6%	$22.64 +7.6%	+31.2%	$813.37M	$2.73B	N/A	2,664	Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRVL) was last updated on 5/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CorVel (CRVL) Competitors

CRVL vs. DVA, CHE, MD, AMN, and CCRN

How does CorVel compare to DaVita?

Summary

How does CorVel compare to Chemed?

Summary

How does CorVel compare to Pediatrix Medical Group?

Summary

How does CorVel compare to AMN Healthcare Services?

Summary

How does CorVel compare to Cross Country Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CorVel (CRVL) Competitors

CRVL vs. DVA, CHE, MD, AMN, and CCRN

How does CorVel compare to DaVita?

Is CRVL or DVA more profitable?

Does the media favor CRVL or DVA?

Which has more risk and volatility, CRVL or DVA?

Do institutionals & insiders hold more shares of CRVL or DVA?

Which has preferable earnings & valuation, CRVL or DVA?

Do analysts recommend CRVL or DVA?

Summary

How does CorVel compare to Chemed?

Do analysts recommend CHE or CRVL?

Which has more volatility & risk, CHE or CRVL?

Does the media favor CHE or CRVL?

Is CHE or CRVL more profitable?

Which has better valuation and earnings, CHE or CRVL?

Do insiders and institutionals hold more shares of CHE or CRVL?

Summary

How does CorVel compare to Pediatrix Medical Group?

Do institutionals and insiders hold more shares of MD or CRVL?

Does the media prefer MD or CRVL?

Is MD or CRVL more profitable?

Which has stronger valuation and earnings, MD or CRVL?

Which has more volatility & risk, MD or CRVL?

Do analysts rate MD or CRVL?

Summary

How does CorVel compare to AMN Healthcare Services?

Do institutionals and insiders hold more shares of AMN or CRVL?

Does the media prefer AMN or CRVL?

Is AMN or CRVL more profitable?

Which has stronger valuation and earnings, AMN or CRVL?

Which has more volatility & risk, AMN or CRVL?

Do analysts rate AMN or CRVL?

Summary

How does CorVel compare to Cross Country Healthcare?

Do analysts rate CRVL or CCRN?

Does the media prefer CRVL or CCRN?

Which has higher earnings and valuation, CRVL or CCRN?

Is CRVL or CCRN more profitable?

Which has more risk & volatility, CRVL or CCRN?

Do insiders & institutionals hold more shares of CRVL or CCRN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools